GlaxoSmithKline and Merck: private-sector collaboration for the elimination of lymphatic filariasis.

Annals of tropical medicine and parasitology

Volumn 103 Suppl 1, Issue , 2009, Pages

  Gustavsen, K M ^a   Bradley, M H ^a   Wright, A L ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; ANTIFILARIAL AGENT; IVERMECTIN;

ARTICLE; DRUG INDUSTRY; ECONOMICS; HEALTH; HEALTH CARE QUALITY; HUMAN; LYMPHATIC FILARIASIS; ORGANIZATION AND MANAGEMENT;

ALBENDAZOLE; DRUG INDUSTRY; ELEPHANTIASIS, FILARIAL; FILARICIDES; HUMANS; IVERMECTIN; PRIVATE SECTOR; PROGRAM EVALUATION; WORLD HEALTH;

MLCS; MLOWN;

EID: 77951637272     PISSN: None     EISSN: 13648594     Source Type: Journal    
DOI: 10.1179/000349809x12502035776478     Document Type: Article

References (0)